Herb Poisoning Differential Diagnoses

1. Singhapricha T, Pomerleau AC. A Case of Strychnine Poisoning from a Southeast Asian Herbal Remedy. J Emerg Med. 2017 Apr. 52 (4):493-495. [Medline].

2. Slifman NR, Obermeyer WR, Aloi BK, Musser SM, Correll WA Jr, Cichowicz SM, et al. Contamination of botanical dietary supplements by Digitalis lanata. N Engl J Med. 1998 Sep 17. 339(12):806-11. [Medline].

3. National Institutes of Health. Jin Bu Huan (Lycopodium serratum). LiverTox. United States National Library of Medicine. Available at http://livertox.nih.gov/JinBuHuan.htm. Accessed: February 11, 2016.

4. Teschke R, Zhang L, Long H, Schwarzenboeck A, Schmidt-Taenzer W, Genthner A, et al. Traditional Chinese Medicine and herbal hepatotoxicity: a tabular compilation of reported cases. Ann Hepatol. 2015 Jan-Feb. 14 (1):7-19. [Medline].

5. Centers for Disease Control and Prevention. Hepatitis temporally associated with an herbal supplement containing artemisinin - Washington, 2008. MMWR Morb Mortal Wkly Rep. 2009 Aug 14. 58(31):854-6. [Medline].

6. Kamiyama T, Nouchi T, Kojima S, Murata N, Ikeda T, Sato C. Autoimmune hepatitis triggered by administration of an herbal medicine. Am J Gastroenterol. 1997 Apr. 92(4):703-4. [Medline].

7. Baker JD. Tradition and toxicity: evidential cultures in the kava safety debate. Soc Stud Sci. 2011 Jun. 41 (3):361-84. [Medline].

8. Showman AF, Baker JD, Linares C, Naeole CK, Borris R, Johnston E, et al. Contemporary Pacific and Western perspectives on `awa (Piper methysticum) toxicology. Fitoterapia. 2015 Jan. 100:56-67. [Medline].

9. Kuchta K, Schmidt M, Nahrstedt A. German Kava Ban Lifted by Court: The Alleged Hepatotoxicity of Kava (Piper methysticum) as a Case of Ill-Defined Herbal Drug Identity, Lacking Quality Control, and Misguided Regulatory Politics. Planta Med. 2015 Dec. 81 (18):1647-53. [Medline].

10. Fox S. Chinese Herb Remains Health Threat Despite Widespread Bans. Medscape Medical News. Available at http://www.medscape.com/viewarticle/780947. March 18, 2013; Accessed: November 16, 2019.

11. Marcus DM, Grollman AP. Toxicity of Botanical Medicines: An Overlooked Global Health Problem. Am J Public Health. 2016 Jan. 106 (1):16-7. [Medline]. [Full Text].

12. Buettner C, Mukamal KJ, Gardiner P, Davis RB, Phillips RS, Mittleman MA. Herbal supplement use and blood lead levels of United States adults. J Gen Intern Med. 2009 Nov. 24(11):1175-82. [Medline]. [Full Text].

13. White J. PC-SPES--a lesson for future dietary supplement research. J Natl Cancer Inst. 2002 Sep 4. 94(17):1261-3. [Medline].

14. Geller AI, Shehab N, Weidle NJ, Lovegrove MC, Wolpert BJ, Timbo BB, et al. Emergency Department Visits for Adverse Events Related to Dietary Supplements. N Engl J Med. 2015 Oct 15. 373 (16):1531-40. [Medline].

15. Gummin DD, Mowry JB, Spyker DA, Brooks DE, Osterthaler KM, Banner W. 2017 Annual Report of the American Association of Poison Control Centers' National Poison Data System (NPDS): 35th Annual Report. Clin Toxicol (Phila). 2018 Dec. 56 (12):1213-1415. [Medline]. [Full Text].

16. Clarke TC, Black LI, Stussman BJ, Barnes PM, Nahin RL. Trends in the use of complementary health approaches among adults: United States, 2002-2012. Natl Health Stat Report. 2015 Feb 10. 1-16. [Medline]. [Full Text].

17. Black LI, Clarke TC, Barnes PM, Stussman BJ, Nahin RL. Use of complementary health approaches among children aged 4-17 years in the United States: National Health Interview Survey, 2007-2012. Natl Health Stat Report. 2015 Feb 10. 1-19. [Medline]. [Full Text].

18. World Health Organization. WHO Traditional Medicine Strategy 2014-2023. WHO.int. Available at http://apps.who.int/iris/bitstream/handle/10665/92455/9789241506090_eng.pdf;jsessionid=334312C6F7F2A7EE582A4A0C602F25CB?sequence=1. 2013; Accessed: November 16, 2019.

Fermin Barrueto, Jr, MD, FAAEM, FACEP Chairman, Department of Emergency Medicine, Upper Chesapeake Health Systems; Clinical Assistant Professor, Department of Emergency Medicine, University of Maryland School of Medicine; Medical Toxicology Consultant, Maryland Poison Control Center

Fermin Barrueto, Jr, MD, FAAEM, FACEP is a member of the following medical societies: American Academy of Clinical Toxicology, American Academy of Emergency Medicine, American College of Emergency Physicians, American College of Medical Toxicology, Society for Academic Emergency Medicine

Disclosure: Nothing to disclose.

Jon Mark Hirshon, MD, PhD, MPH Professor, Department of Emergency Medicine, University of Maryland School of Medicine

Jon Mark Hirshon, MD, PhD, MPH is a member of the following medical societies: Alpha Omega Alpha, American Academy of Emergency Medicine, American College of Emergency Physicians, American Public Health Association, Society for Academic Emergency Medicine

Disclosure: Serve(d) as a director, officer, partner, employee, advisor, consultant or trustee for: Pfizer; Novartis<br/>Received income in an amount equal to or greater than $250 from: Pfizer; Novartis.

Michael A Miller, MD Clinical Professor of Emergency Medicine, Medical Toxicologist, Department of Emergency Medicine, Texas A&M Health Sciences Center; CHRISTUS Spohn Emergency Medicine Residency Program

Michael A Miller, MD is a member of the following medical societies: American College of Medical Toxicology

Disclosure: Nothing to disclose.

B Zane Horowitz, MD, FACMT Professor, Department of Emergency Medicine, Oregon Health and Sciences University; Medical Director, Oregon Poison Center; Medical Director, Alaska Poison Control System

B Zane Horowitz, MD, FACMT is a member of the following medical societies: American College of Medical Toxicology

Disclosure: Nothing to disclose.

John T VanDeVoort, PharmD Regional Director of Pharmacy, Sacred Heart and St Joseph's Hospitals

John T VanDeVoort, PharmD is a member of the following medical societies: American Society of Health-System Pharmacists

Disclosure: Nothing to disclose.

• Print this section
• Print the entire contents of
• Print the entire contents of article